Tags |
|
|
Links |
|
|
Digg It - Companies Within Companies - The Worst Of Both Worlds
There is a different kind of company experience lurking in corporate America that awaits the unsuspecting candidate who is hoping to find a stable and beneficial work environment. With the advent of today’
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
s large corporation environment, there are many smaller companies caught up in the practice of being purchased and absorbed by big companies that are looking to stifle competition or increase their own mark
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
et share by acquiring successful small business operations.
Often, when these small to middle sized companies are absorbed by the corporate giants, the attraction for selling out is to tap into the financi
Often, when these small to middle sized companies are absorbed by the corporate giants, the attraction for selling out is to tap into the financi
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
al resources, brand recognition, and marketing success of the larger company, and to bring the operations of the smaller organization to the next level. Employees of these smaller companies are assured tha
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
t they will be able to continue with doing business as usual, and operations will be smoothly transitioned into adapting to the new world of benefits from a far reaching business venture. This image is rei
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
nforced by the impression that the small business was selected because of their lean operating style and quick response to customer expectations.
As the dust settles from the back slapping and big promises
As the dust settles from the back slapping and big promises
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
offered on both sides of the deal, the reality of acquisition presents a starkly different picture. Just as it is not practical to try to fit a round peg in a square hole, the consequences of merging two
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
very different styles of organization begin to surface. As the large corporation assesses its new assets, the company may start out by allowing the smaller company to continue operating at arm’s length fro
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
m the more cumbersome practices of the conglomerate. Over time, the larger company by nature will begin to impose its own views on how the smaller operations should be carried out, and will introduce proce
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
dures and policies for business practices that meet the large scale tenets for accountability. These requirements create more bureaucracy, push decisions higher up on the corporate ladder, and reduce the a
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
ility for the smaller organization to maintain their lean operation and production goals. Employees of the smaller company begin to get confused by the overwhelming changes to their environment and working
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
style, as the management sends mixed signals on goals and intent. When the local management loses the argument for continued autonomy, and is forced to conform or leave the company, employees are further
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
shaken by the sudden departure of familiar faces, and forced to adapt to directives from absentee management in a difficult to reach layer of the larger corporation.
When the lean and mean structure of rap
When the lean and mean structure of rap
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
id response begins to grind to what seems like a screeching halt, the larger corporation begins to assess whether or not the current operations of the smaller group are optimal for their own corporate succe
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
ss. Rumors and truths about moving functions to other areas of the large corporation begin to circulate, and long time employees of the small operation begin to read the writing on the wall and bail out fo
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
r greener pastures. Work loads increase dramatically, and then suddenly evaporate into what appears to be indecision. Talk of outsourcing responsibilities to more cost effective business centers are circu
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
lated, and employees begin to wonder if they will be part of the changes to come. While all this chaos continues, the people who were responsible for earlier successes are culled from the work force, and t
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
he remaining employees fight to maintain their value and identity.
For any new employees that are brought into such environments, the security and benefit of working in this atmosphere is questionable from
For any new employees that are brought into such environments, the security and benefit of working in this atmosphere is questionable from
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
the start. It is difficult for anyone to absorb the confusion of working for a combination small and large company at the same time and rapid turnover becomes an obvious consequence. This scenario is bec
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
oming a more prevalent aspect of working in today’s business environment, and for those people who are considering an offer of employment; the dynamics are well worth considering before accepting a position
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/8957/diggit-Companies-Within-Companies--The-Worst-Of-Both-Worlds.html">Companies Within Companies - The Worst Of Both Worlds</a>
BB link (for phorums):
[url=http://www.diggit.org.ua/article/8957/diggit-Companies-Within-Companies--The-Worst-Of-Both-Worlds.html]Companies Within Companies - The Worst Of Both Worlds[/url]
Related Articles:
Business Merchant Account - Get One
Could Ray Kroc have founded McDonalds in the Era of Sarbaines Oxley?
5 Steps To Getting A Job As A Video Game Tester
Bookmark it:
|